Abbott Laboratories Buys AP214 Hormone From Action Pharma for $110 Million

ABBOTT PARK, Ill. and AARHUS, Denmark, May 3, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) and Action Pharma A/S, a privately owned company, today announced that they have entered into an agreement in whic…
Read the full story: BioSpace.com Featured News